Insights Into CRISPR Therapeutics AG (CRSP) Exposure By Institutions

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

CRISPR Therapeutics AG is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of CRISPR Therapeutics AG is $5.09B. A total of 1.1 million shares were traded on the day, compared to an average of 1.30M shares.

In the most recent transaction, Kulkarni Samarth sold 19,582 shares of CRSP for 59.91 per share on Apr 15 ’24. After the transaction, the Chief Executive Officer now owns 208,122 company shares. In a previous transaction on Mar 15 ’24, Kulkarni Samarth sold 20,000 shares at 72.48 per share. CRSP shares that Chief Executive Officer owns now total 208,122.

Among the insiders who sold shares, Prasad Raju disposed of 3,524 shares on Mar 15 ’24 at a per-share price of $72.69. This resulted in the Chief Financial Officer holding 6,476 shares of CRSP after the transaction. In another insider transaction, Kulkarni Samarth sold 4,583 shares at $74.44 per share on Mar 12 ’24. Company shares held by the Chief Executive Officer now total 208,122.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, CRSP has a high of $91.10 and a low of $37.55.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. CRSP’s latest balance sheet shows that the firm has $2.38B in Cash & Short Term Investments as of fiscal 2021. There were $225.03M in debt and $119.88M in liabilities at the time. Its Book Value Per Share was $24.56, while its Total Shareholder’s Equity was $2.40B.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRSP is Buy with a score of 3.81.

Most Popular

Related Posts